Insulin-Like Growth Factor-I and Risk of Type 2 Diabetes and Coronary Heart Disease: Molecular Epidemiology
作者： Manjinder S. Sandhu
DOI: 10.1159/000085755
关键词:
摘要: Insulin-like growth factors (IGFs) play a fundamental role in somatic and cellular differentiation, metabolism survival. Indeed, the processes linking nutrition, metabolism and are
sci-hub.se 参考文章(53)
Dominic J. Withers, Deborah J. Burks, Heather H. Towery, Shari L. Altamuro, Carrie L. Flint, Morris F. White, Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling Nature Genetics. ,vol. 23, pp. 32- 40 ,(1999) , 10.1038/12631
Gillian C.L. Johnson, Laura Esposito, Bryan J. Barratt, Annabel N. Smith, Joanne Heward, Gianfranco Di Genova, Hironori Ueda, Heather J. Cordell, Iain A. Eaves, Frank Dudbridge, Rebecca C.J. Twells, Felicity Payne, Wil Hughes, Sarah Nutland, Helen Stevens, Phillipa Carr, Eva Tuomilehto-Wolf, Jaakko Tuomilehto, Stephen C.L. Gough, David G. Clayton, John A. Todd, Haplotype tagging for the identification of common disease genes Nature Genetics. ,vol. 29, pp. 233- 237 ,(2001) , 10.1038/NG1001-233
Dominic J. Withers, Julio Sanchez Gutierrez, Heather Towery, Deborah J. Burks, Jian-Ming Ren, Stephen Previs, Yitao Zhang, Dolores Bernal, Sebastian Pons, Gerald I. Shulman, Susan Bonner-Weir, Morris F. White, Disruption of IRS-2 causes type 2 diabetes in mice Nature. ,vol. 391, pp. 900- 904 ,(1998) , 10.1038/36116
Jun Ren, Willis K. Samson, James R. Sowers, Insulin-like Growth Factor I as aÈCardiac Hormone: Physiological and Pathophysiological Implications in Heart Disease Journal of Molecular and Cellular Cardiology. ,vol. 31, pp. 2049- 2061 ,(1999) , 10.1006/JMCC.1999.1036
MehboobA. Hussain, E.Rudolf Froesch, Treatment of type A insulin resistance with insulin-like growth factor-I The Lancet. ,vol. 341, pp. 1536- 1537 ,(1993) , 10.1016/0140-6736(93)90674-6
Shoshana Yakar, Mary L Bouxsein, Martin Haluzik, Bethel Stannard, Vaida Glatt, Jennifer Setser, Derek LeRoith, John J. Kopchick, Hong Zhao, Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice Journal of Clinical Investigation. ,vol. 113, pp. 96- 105 ,(2004) , 10.1172/JCI17763
G Di Cola, M H Cool, D Accili, Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. Journal of Clinical Investigation. ,vol. 99, pp. 2538- 2544 ,(1997) , 10.1172/JCI119438
D.B Dunger, C.L. Acerini, Does recombinant human insulin‐like growth factor‐1 have a role in the treatment of diabetes? Diabetic Medicine. ,vol. 14, pp. 723- 731 ,(1997) , 10.1002/(SICI)1096-9136(199709)14:9<723::AID-DIA480>3.0.CO;2-S
David R. Clemmons, Alan C. Moses, Malcolm J. McKay, Andreas Sommer, David M. Rosen, John Ruckle, The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. The Journal of Clinical Endocrinology and Metabolism. ,vol. 85, pp. 1518- 1524 ,(2000) , 10.1210/JCEM.85.4.6559
Marc Y. Donath, Gabor Sütsch, Xia-Wei Yan, Bruno Piva, Hans-Peter Brunner, Yvonne Glatz, Jürgen Zapf, Ferenc Follath, E. Rudolf Froesch, Wolfgang Kiowski, Acute Cardiovascular Effects of Insulin-Like Growth Factor I in Patients with Chronic Heart Failure The Journal of Clinical Endocrinology and Metabolism. ,vol. 83, pp. 3177- 3183 ,(1998) , 10.1210/JCEM.83.9.5122